hesselberg - Castle Creek Biosciences, Inc. : Castle Creek Biosciences, Inc.

About
Technology
Pipeline & Clinical Trials
Patients & Families
- Epidermolysis Bullosa (EB)
- Tyrosinemia
Newsroom

Contact Us

Press Releases

hesselberg

Jul 19, 2020

hesselberg

Recent Posts

Castle Creek Biosciences Announces Publication of Preclinical Study for Potential In Vivo Gene Therapy in Nature Communications
Castle Creek Biosciences Raises $112.8 Million to Advance Novel Gene Therapies and Expand Pipeline
American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Hybrid Conference
Society of Investigative Dermatology (SID) Annual Meeting

Castle Creek Biosciences, Inc.
405 Eagleview Boulevard
Exton, PA 19341

Connect with us:

©2022 Castle Creek Biosciences, Inc. All Rights Reserved. The registered dual crescent logo and “Castle Creek Biosciences” are trademarks of Castle Creek Biosciences, LLC.

Privacy Policy | Terms of Use